# FDA recall D-1720-2019

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2019-07-17.

## Product

Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg, 100 tablet bottle, Rx only, Manufactured by for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by: Lupin Limited, Pithampur, INDIA NDC 68180-518-01

## Reason for recall

Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles.

## Distribution

Product was distributed to wholesalers/distributors and supermarket and drug chains throughout the United States.

## Key facts

- **Recall number:** D-1720-2019
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-07-17
- **Report date:** 2019-08-21
- **Termination date:** 2020-09-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1720-2019

## Citation

> AI Analytics. FDA recall D-1720-2019. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1720-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*